Telemedicine and the Changing Cost of Care

How remote consultations are reshaping healthcare's cost structure, access, and some of the market failures covered earlier in this module.

Telemedicine - receiving medical consultations, diagnoses, and even some treatment remotely, over video or phone rather than in person - moved from a niche convenience to a mainstream part of healthcare delivery remarkably quickly. Its economics are still settling into place, but the underlying shifts it creates are already reshaping several of the ideas covered earlier in this module, from overhead costs to information asymmetry to access itself.

Why a remote visit can genuinely cost less to deliver

A significant share of a traditional medical visit’s cost has nothing to do with the medical judgment involved - it’s tied to overhead cost: the physical space, front-desk staff, cleaning, equipment, and scheduling infrastructure required to run a physical office. A telemedicine visit removes much of that physical overhead: no exam room needs to be cleaned and prepared, no in-person staff need to manage a waiting room, and a single provider can potentially see patients from a far wider geographic area without either party traveling. For many routine, low-complexity visits - a follow-up, a prescription renewal, a discussion of test results - this can mean a genuinely lower cost of delivering the same medical judgment.

Where the savings do and don't apply

A telemedicine visit to discuss medication side effects or review lab results can be handled just as effectively remotely as in person, cutting out the overhead of an in-person visit almost entirely. A visit requiring a physical exam, imaging, or a procedure - a suspected broken bone, a skin biopsy - still generally requires an in-person appointment, since no video call can replace hands-on examination or physical equipment. Telemedicine's cost advantage is real, but it applies unevenly across different types of care, not universally.

The payment question insurers had to solve

Telemedicine’s rapid growth created a genuine policy question: should a remote visit be reimbursed at the same rate as an equivalent in-person visit? Reimbursement parity refers to policies requiring insurers to pay the same rate for a telemedicine visit as for a comparable in-person one. Advocates argue the medical judgment delivered is equivalent and shouldn’t be devalued just because of the delivery method; critics argue that if delivering the visit costs providers meaningfully less, paying the same rate mostly just increases provider profit margins rather than passing overhead savings on to patients or insurers. How different insurers and countries have settled this question significantly shapes how much telemedicine actually saves the overall system versus simply shifting where the savings land.

Removing one access barrier while other ones remain

Telemedicine can meaningfully reduce certain access barriers - obstacles that prevent people from getting care, such as long travel distances to the nearest specialist, difficulty taking time off work for an in-person appointment, or a shortage of providers in a rural area entirely. A patient hours from the nearest specialist can potentially get an equivalent remote consultation instead. At the same time, telemedicine introduces or worsens other barriers: it requires reliable internet access and a comfortable working device, which not every patient has, and it’s a genuinely difficult format for patients who are blind or have low vision, unless platforms and providers deliberately design for screen-reader accessibility and compatible voice interfaces. Telemedicine doesn’t remove access barriers so much as it trades one specific set of barriers for a different one.

"Telemedicine is simply a cheaper, universally better option"

Telemedicine offers real, meaningful cost and access advantages for many kinds of routine care, but it isn't a universal replacement for in-person medicine, and it isn't automatically accessible to everyone. Framing it as a simple upgrade misses both the categories of care that genuinely still require in-person visits and the real access barriers it can introduce for patients without reliable internet, a suitable device, or accessible remote-care tools.

Closing out the module

Telemedicine is a useful place to end this module, because it shows the same underlying forces from the first lesson - information asymmetry, the third-party payer system, and uneven access - reshaping themselves around a genuinely new delivery method, rather than disappearing. The specific technology changes; the underlying economics of healthcare remains something every new innovation still has to work within.

Key takeaways

Telemedicine can reduce overhead costs for many routine, low-complexity types of care.
Not all care can move remotely - anything requiring a physical exam or procedure still generally needs an in-person visit.
Reimbursement parity policies significantly shape whether telemedicine's cost savings reach patients or mostly stay with providers.
Telemedicine reduces some access barriers, like travel distance, while introducing others, like the need for reliable internet and accessible platforms.
New care delivery methods still operate within the same underlying economic forces covered throughout this module.